Zhejiang Qianjiang Biochemical Co Ltd (600796) - Net Assets
Based on the latest financial reports, Zhejiang Qianjiang Biochemical Co Ltd (600796) has net assets worth CN¥3.75 Billion CNY (≈ $548.04 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥7.45 Billion ≈ $1.09 Billion USD) and total liabilities (CN¥3.71 Billion ≈ $542.84 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Zhejiang Qianjiang Biochemical Co Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥3.75 Billion |
| % of Total Assets | 50.24% |
| Annual Growth Rate | 16.3% |
| 5-Year Change | 12.14% |
| 10-Year Change | 483.58% |
| Growth Volatility | 70.45 |
Zhejiang Qianjiang Biochemical Co Ltd - Net Assets Trend (1994–2025)
This chart illustrates how Zhejiang Qianjiang Biochemical Co Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see how much is Zhejiang Qianjiang Biochemical Co Ltd worth.
Annual Net Assets for Zhejiang Qianjiang Biochemical Co Ltd (1994–2025)
The table below shows the annual net assets of Zhejiang Qianjiang Biochemical Co Ltd from 1994 to 2025. Also explore Zhejiang Qianjiang Biochemical Co Ltd (600796) equity growth momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥3.71 Billion ≈ $542.18 Million |
+4.17% |
| 2024-12-31 | CN¥3.56 Billion ≈ $520.47 Million |
+1.72% |
| 2023-12-31 | CN¥3.50 Billion ≈ $511.68 Million |
+2.78% |
| 2022-12-31 | CN¥3.40 Billion ≈ $497.83 Million |
+2.97% |
| 2021-12-31 | CN¥3.30 Billion ≈ $483.49 Million |
+381.91% |
| 2020-12-31 | CN¥685.62 Million ≈ $100.33 Million |
+8.12% |
| 2019-12-31 | CN¥634.15 Million ≈ $92.80 Million |
+3.42% |
| 2018-12-31 | CN¥613.20 Million ≈ $89.73 Million |
-7.63% |
| 2017-12-31 | CN¥663.83 Million ≈ $97.14 Million |
+4.56% |
| 2016-12-31 | CN¥634.89 Million ≈ $92.90 Million |
+6.36% |
| 2015-12-31 | CN¥596.94 Million ≈ $87.35 Million |
+5.30% |
| 2014-12-31 | CN¥566.90 Million ≈ $82.96 Million |
+2.65% |
| 2013-12-31 | CN¥552.27 Million ≈ $80.81 Million |
+6.59% |
| 2012-12-31 | CN¥518.15 Million ≈ $75.82 Million |
+3.91% |
| 2011-12-31 | CN¥498.64 Million ≈ $72.97 Million |
-18.72% |
| 2010-12-31 | CN¥613.47 Million ≈ $89.77 Million |
+40.39% |
| 2009-12-31 | CN¥436.97 Million ≈ $63.94 Million |
+0.08% |
| 2008-12-31 | CN¥436.63 Million ≈ $63.89 Million |
-24.51% |
| 2007-12-31 | CN¥578.39 Million ≈ $84.64 Million |
+19.67% |
| 2006-12-31 | CN¥483.31 Million ≈ $70.72 Million |
+9.59% |
| 2005-12-31 | CN¥441.02 Million ≈ $64.53 Million |
+1.83% |
| 2004-12-31 | CN¥433.08 Million ≈ $63.37 Million |
+12.27% |
| 2003-12-31 | CN¥385.75 Million ≈ $56.45 Million |
+4.63% |
| 2002-12-31 | CN¥368.69 Million ≈ $53.95 Million |
+45.33% |
| 2001-12-31 | CN¥253.69 Million ≈ $37.12 Million |
-0.65% |
| 2000-12-31 | CN¥255.34 Million ≈ $37.36 Million |
-3.06% |
| 1999-12-31 | CN¥263.40 Million ≈ $38.54 Million |
+67.46% |
| 1998-12-31 | CN¥157.29 Million ≈ $23.02 Million |
+22.81% |
| 1997-12-31 | CN¥128.08 Million ≈ $18.74 Million |
+124.36% |
| 1996-12-31 | CN¥57.09 Million ≈ $8.35 Million |
+36.43% |
| 1995-12-31 | CN¥41.84 Million ≈ $6.12 Million |
+21.88% |
| 1994-12-31 | CN¥34.33 Million ≈ $5.02 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Zhejiang Qianjiang Biochemical Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 52400.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥982.77 Million | 28.57% |
| Other Components | CN¥2.46 Billion | 71.43% |
| Total Equity | CN¥3.44 Billion | 100.00% |
Zhejiang Qianjiang Biochemical Co Ltd Competitors by Market Cap
The table below lists competitors of Zhejiang Qianjiang Biochemical Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Vestum AB (publ)
ST:VESTUM
|
$645.47 Million |
|
Sansec Technology Co. Ltd. A
SHG:688489
|
$645.93 Million |
|
Baskent Dogalgaz Dagitim Gayrimenkul Yatirim Ortakligi AS
IS:BASGZ
|
$645.94 Million |
|
Haoxiangni Jujube Co Ltd
SHE:002582
|
$645.97 Million |
|
Pantoro Limited
F:RKN
|
$644.80 Million |
|
mobilezone ag
SW:MOZN
|
$644.79 Million |
|
Kempower Oyj
HE:KEMPOWR
|
$644.61 Million |
|
Hainan Haiqi Transportation Group Co Ltd
SHG:603069
|
$644.60 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Zhejiang Qianjiang Biochemical Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 3,276,177,000 to 3,440,048,457, a change of 163,871,457 (5.0%).
- Net income of 166,364,625 contributed positively to equity growth.
- Dividend payments of 98,271,558 reduced retained earnings.
- Other comprehensive income decreased equity by 141,794,865.
- Other factors increased equity by 237,573,254.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥166.36 Million | +4.84% |
| Dividends Paid | CN¥98.27 Million | -2.86% |
| Other Comprehensive Income | CN¥-141.79 Million | -4.12% |
| Other Changes | CN¥237.57 Million | +6.91% |
| Total Change | CN¥- | 5.00% |
Book Value vs Market Value Analysis
This analysis compares Zhejiang Qianjiang Biochemical Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.28x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 44.83x to 1.28x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1994-12-31 | CN¥0.11 | CN¥5.09 | x |
| 1995-12-31 | CN¥0.14 | CN¥5.09 | x |
| 1996-12-31 | CN¥0.19 | CN¥5.09 | x |
| 1997-12-31 | CN¥0.42 | CN¥5.09 | x |
| 1998-12-31 | CN¥0.51 | CN¥5.09 | x |
| 1999-12-31 | CN¥0.75 | CN¥5.09 | x |
| 2000-12-31 | CN¥0.83 | CN¥5.09 | x |
| 2001-12-31 | CN¥0.83 | CN¥5.09 | x |
| 2002-12-31 | CN¥1.29 | CN¥5.09 | x |
| 2003-12-31 | CN¥1.27 | CN¥5.09 | x |
| 2004-12-31 | CN¥1.38 | CN¥5.09 | x |
| 2005-12-31 | CN¥1.40 | CN¥5.09 | x |
| 2006-12-31 | CN¥1.52 | CN¥5.09 | x |
| 2007-12-31 | CN¥1.85 | CN¥5.09 | x |
| 2008-12-31 | CN¥1.38 | CN¥5.09 | x |
| 2009-12-31 | CN¥1.50 | CN¥5.09 | x |
| 2010-12-31 | CN¥1.74 | CN¥5.09 | x |
| 2011-12-31 | CN¥1.45 | CN¥5.09 | x |
| 2012-12-31 | CN¥1.71 | CN¥5.09 | x |
| 2013-12-31 | CN¥1.74 | CN¥5.09 | x |
| 2014-12-31 | CN¥1.71 | CN¥5.09 | x |
| 2015-12-31 | CN¥1.94 | CN¥5.09 | x |
| 2016-12-31 | CN¥2.03 | CN¥5.09 | x |
| 2017-12-31 | CN¥2.16 | CN¥5.09 | x |
| 2018-12-31 | CN¥1.94 | CN¥5.09 | x |
| 2019-12-31 | CN¥1.87 | CN¥5.09 | x |
| 2020-12-31 | CN¥2.90 | CN¥5.09 | x |
| 2021-12-31 | CN¥4.30 | CN¥5.09 | x |
| 2022-12-31 | CN¥3.51 | CN¥5.09 | x |
| 2023-12-31 | CN¥3.57 | CN¥5.09 | x |
| 2024-12-31 | CN¥3.69 | CN¥5.09 | x |
| 2025-12-31 | CN¥3.97 | CN¥5.09 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Zhejiang Qianjiang Biochemical Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.84%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.82%
- • Asset Turnover: 0.22x
- • Equity Multiplier: 2.21x
- Recent ROE (4.84%) is below the historical average (7.33%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1994 | 13.02% | 6.85% | 0.94x | 2.03x | CN¥1.04 Million |
| 1995 | 25.97% | 10.58% | 1.17x | 2.10x | CN¥6.68 Million |
| 1996 | 26.70% | 12.85% | 1.05x | 1.97x | CN¥9.53 Million |
| 1997 | 16.99% | 15.69% | 0.86x | 1.26x | CN¥8.95 Million |
| 1998 | 16.54% | 15.81% | 0.67x | 1.55x | CN¥10.08 Million |
| 1999 | 16.11% | 17.78% | 0.59x | 1.54x | CN¥13.90 Million |
| 2000 | 14.31% | 18.07% | 0.48x | 1.65x | CN¥10.80 Million |
| 2001 | 10.52% | 13.14% | 0.46x | 1.76x | CN¥1.31 Million |
| 2002 | 4.30% | 8.28% | 0.38x | 1.37x | CN¥-22.18 Million |
| 2003 | 4.89% | 7.93% | 0.42x | 1.46x | CN¥-19.66 Million |
| 2004 | 7.28% | 10.65% | 0.43x | 1.59x | CN¥-11.33 Million |
| 2005 | 6.71% | 9.97% | 0.34x | 1.97x | CN¥-13.97 Million |
| 2006 | 6.63% | 7.10% | 0.46x | 2.01x | CN¥-15.50 Million |
| 2007 | 5.81% | 7.79% | 0.40x | 1.85x | CN¥-23.39 Million |
| 2008 | -18.58% | -20.46% | 0.47x | 1.94x | CN¥-119.08 Million |
| 2009 | 6.06% | 7.37% | 0.45x | 1.83x | CN¥-17.10 Million |
| 2010 | 10.35% | 11.50% | 0.40x | 2.27x | CN¥1.69 Million |
| 2011 | 2.07% | 1.80% | 0.46x | 2.50x | CN¥-38.38 Million |
| 2012 | 3.51% | 3.95% | 0.33x | 2.65x | CN¥-32.58 Million |
| 2013 | 5.75% | 6.36% | 0.42x | 2.14x | CN¥-22.64 Million |
| 2014 | 4.10% | 5.62% | 0.36x | 2.02x | CN¥-32.22 Million |
| 2015 | 4.64% | 5.60% | 0.44x | 1.87x | CN¥-30.71 Million |
| 2016 | 5.42% | 7.39% | 0.43x | 1.70x | CN¥-27.72 Million |
| 2017 | 6.49% | 8.77% | 0.45x | 1.66x | CN¥-22.15 Million |
| 2018 | -7.72% | -10.08% | 0.47x | 1.64x | CN¥-102.44 Million |
| 2019 | 3.21% | 5.04% | 0.43x | 1.46x | CN¥-40.53 Million |
| 2020 | 5.16% | 5.09% | 1.63x | 0.62x | CN¥-90.04 Million |
| 2021 | 5.11% | 7.28% | 0.31x | 2.24x | CN¥-141.36 Million |
| 2022 | 6.83% | 10.26% | 0.30x | 2.22x | CN¥-95.41 Million |
| 2023 | 6.71% | 10.36% | 0.30x | 2.19x | CN¥-103.13 Million |
| 2024 | 4.88% | 9.05% | 0.23x | 2.30x | CN¥-167.61 Million |
| 2025 | 4.84% | 9.82% | 0.22x | 2.21x | CN¥-177.64 Million |
Industry Comparison
This section compares Zhejiang Qianjiang Biochemical Co Ltd's net assets metrics with peer companies in the Agricultural Inputs industry.
Industry Context
- Industry: Agricultural Inputs
- Average net assets among peers: $5,065,162,570
- Average return on equity (ROE) among peers: -54.67%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Zhejiang Qianjiang Biochemical Co Ltd (600796) | CN¥3.75 Billion | 13.02% | 0.99x | $645.46 Million |
| Hubei Yihua Chemical Industry Co Ltd (000422) | $290.93 Million | 18.67% | 0.30x | $1.94 Billion |
| Nanjing Red Sun Co Ltd (000525) | $591.59 Million | -632.89% | 15.41x | $887.03 Million |
| ADAMA Ltd (000553) | $21.43 Billion | 1.65% | 1.18x | $1.79 Billion |
| Grand Industrial Holding Co Ltd (000626) | $2.01 Billion | 15.34% | 3.29x | $684.27 Million |
| Sichuan Meifeng Chemical Industry Co Ltd (000731) | $628.24 Million | 9.39% | 0.26x | $664.97 Million |
| Qinghai Salt Lake Industry Co.Ltd (000792) | $11.65 Billion | 38.44% | 1.17x | $19.26 Billion |
| Asia Potash International Investment Guangzhou Co Ltd (000893) | $3.89 Billion | -17.67% | 0.09x | $5.37 Billion |
| Hubei Xinyangfeng Fertilizer Co Ltd (000902) | $8.22 Billion | 14.71% | 0.60x | $2.53 Billion |
| Sichuan Lutianhua Co Ltd (000912) | $2.03 Billion | 5.63% | 0.81x | $968.27 Million |
| Guangxi Hechi Chemical Co Ltd (000953) | $-89.10 Million | 0.00% | 0.00x | $330.56 Million |
About Zhejiang Qianjiang Biochemical Co Ltd
Zhejiang Qianjiang Biochemical Co., Ltd., together with its subsidiaries, research, develops, produces, sells, and services biopesticides in China and internationally. The company offers biopesticide products comprising plant growth regulators consisting of gibberellic acid and gibberellic acid A4+A7; insecticides, such as avermectin and emamectin benzoate; and fungicides, including jinggangmycin… Read more